Market Tracker

01/20 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.02
Delayed Data
As of Jan 20
 -0.41 / -1.30%
Today’s Change
16.64
Today|||52-Week Range
42.49
+7.56%
Year-to-Date
Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016
Jan 13 / MotleyFool.com - Paid Partner Content
3 Companies Whose Sales Could Double in 2017
Jan 07 / MotleyFool.com - Paid Partner Content
Top Stocks to Buy in 2017
Jan 07 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close31.43
Today’s open31.46
Day’s range30.93 - 31.65
Volume1,288,562
Average volume (3 months)2,588,358
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-44.15%
Earnings growth (next 5 years)+15.31%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book16.04

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-15.86-2.03%
PTHNPatheon NV-0.27-0.97%
TAROTaro Pharmaceutical ...-1.34-1.32%
ALNYAlnylam Pharmaceutic...-0.12-0.31%
Data as of 4:03pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts